Increased Risk of Genetic and Epigenetic Instability in Human Embryonic Stem Cells Associated with Specific Culture Conditions
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The self-renewal and differentiation capacities of human pluripotent stem cells (hPSCs) make them a promising source of material for cell transplantation therapy, drug development, and studies of cellular differentiation and development. However, the large numbers of cells necessary for many of these applications require extensive expansion of hPSC cultures, a process that has been associated with genetic and epigenetic alterations. We have performed a combinatorial study on both hESCs and hiPSCs to compare the effects of enzymatic vs. mechanical passaging, and feeder-free vs. mouse embryonic fibroblast feeder substrate, on the genetic and epigenetic stability and the phenotypic characteristics of hPSCs. In extensive experiments involving over 100 continuous passages, we observed that both enzymatic passaging and feeder-free culture were associated with genetic instability, higher rates of cell proliferation, and persistence of OCT4/POU5F1-positive cells in teratomas, with enzymatic passaging having the stronger effect. In all combinations of culture conditions except for mechanical passaging on feeder layers, we noted recurrent deletions in the genomic region containing the tumor suppressor gene TP53, which was associated with decreased mRNA expression of TP53, as well as alterations in the expression of several downstream genes consistent with a decrease in the activity of the TP53 pathway. Among the hESC cultures, we also observed culture-associated variations in global gene expression and DNA methylation. The effects of enzymatic passaging and feeder-free conditions were also observed in hiPSC cultures. Our results highlight the need for careful assessment of the effects of culture conditions on cells intended for clinical therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig 4 Chromosome 12 detail in MefEnz. Detailed view of the duplications in chromosome 12 for MefEnz. A. The green areas indicate the regions of duplication that were identified by CNVPartition 3.2.0. The areas that were detected manually rather than by the software are indicated in a scale from grey to black. Estimates of the percentage of the population carrying the duplication were performed using the BAF distance for heterozygous SNPs as described [3]. B. LogR Ratio (LRR) and BAF plots of replicate A of MefEnz showed changes in genetic aberrations over time. C. The CNV data were further validated via TaqMan Copy Number Assays. Probe 1 corresponds to Hs03295596_cn, Probe 2 to Hs04404518_cn, Probe 3 to Hs03812366_cn, Probe 4 to Hs03841181_cn, Probe 5 to Hs06947059_cn, and Probe 6 to Hs06363301_cn. D. Karyotyping results confirmed the CNV data.](https://figures.cochat.ai/paper-figures/1571f5b4a88f448b827c4e9c56e2c374/increased-risk-of-genetic-and-epigenetic-instability-in-human-embryonic-stem-figure-4.jpg)



![Fig 8 DNA Methylation. A. X Chromosome DNA Methylation and XIST Expression. Methylation levels of genes in the X-chromosome (S6A Table) are shown on the heatmap. Hierarchical clustering was performed on the samples, as indicated by the dendrogram. The genes are ordered according to their location (from the beginning to the end of the chromosome). Samples that show loss of DNA methylation for the “Enz” cluster are highlighted in blue, those that show DNA methylation for the “Ecm” cluster are highlighted in pink, and for both clusters in mauve. Genes located in the regions of loss of DNA methylation are listed to the right of the heatmap. XIST expression is shown on the line graph, with the detection limit for the microarray indicated by the red line. B. DNA methylation at imprinted loci. Methylation levels for imprinted probes (S6B Table) are shown on the heatmap. Hierarchical clustering was performed on the samples, as indicated by the dendrogram. The genes are ordered according to chromosome location; genes are listed to the left. The inset at the right shows a detail of the NESP/GNAS complex locus, indicating the positions of the CpG sites that were hypermethylated (red triangle) vs. hypomethylated (green triangle) in the late passage samples relative to the NESP/GNAS and NESPAS exons. C, D, E. Heatmaps showing differential DNA methylation genes for early vs. late passage (C), mechanical vs. enzymatic passage (D), and Mef vs. Ecm substrate (E). In heatmap (C), the black boxes indicate genes for which the DNA methylation levels in the late passage MefMech (P103) samples was more similar to those in the early passage samples. Probes were selected by multivariate regression. Functional enrichments identified by GREAT analysis are shown to the right of the heatmaps, visualized using REVIGO [13]. Samples were arranged according to passage and culture method, and hierarchical clustering was performed on the genes only. In the functional enrichment results, the size of the node indicated the number of contributing GO terms, and color of the nodes indicates the FDR (darker color for lower FDR), and the edge length indicates the similarity between GO terms (shorter edge for more similar terms).](https://figures.cochat.ai/paper-figures/7b4cd5bcf4c148efbc9443ce7db36da4/increased-risk-of-genetic-and-epigenetic-instability-in-human-embryonic-stem-figure-8.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, the negative impact of enzymatic versus mechanical passaging was also observed in iPSC cultures with an MEF layer.”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [54]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although the mutational burden comes mostly from starting cells, the cell culture, passaging reagents, and passaging method could impact the mutational rate [13,14,15,54,55].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [54]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a long-term study with more than 100 passages of iPSCs, a group of researchers found that enzymatic passaging caused a higher growth rate, and more genetic instability and OCT4-positive cells in teratoma compared to mechanical passaging [54].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [54]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a long-term study with more than 100 passages of iPSCs, a group of researchers found that enzymatic passaging caused a higher growth rate, and more genetic instability and OCT4-positive cells in teratoma compared to mechanical passaging [54].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [54]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a long-term study with more than 100 passages of iPSCs, a group of researchers found that enzymatic passaging caused a higher growth rate, and more genetic instability and OCT4-positive cells in teratoma compared to mechanical passaging [54].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [54]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
REVIGO summarizes and visualizes long lists of gene ontology terms
Supek, F., Bošnjak, M., Škunca, N., & Šmuc, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021800 · Cited by 6,264 · cited 1×
“Pathway analysis was performed using GREAT [12], and visualized using REVIGO [13].”
MethodGREAT improves functional interpretation of cis-regulatory regions
McLean, C. Y., Bristor, D., Hiller, M., Clarke, S. L., Schaar, B. T., Lowe, C. B., Wenger, A. M., & Bejerano, G. (2010) · Nature Biotechnology · doi:10.1038/nbt.1630 · Cited by 4,502
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,066
Characterization of human embryonic stem cell lines by the International Stem Cell Initiative
Initiative, T. I. S. C. (2007) · Nature Biotechnology · doi:10.1038/nbt1318 · Cited by 1,073
Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells
Draper, J. S., Smith, K., Gokhale, P., Moore, H. D., Maltby, E., Johnson, J., Meisner, L., Zwaka, T. P., Thomson, J. A., & Andrews, P. W. (2004) · Nature Biotechnology · doi:10.1038/nbt922 · Cited by 1,021
Copy number variation and selection during reprogramming to pluripotency
Hussein, S. M., Batada, N. N., Vuoristo, S., Ching, R. W., Autio, R., Närvä, E., Ng, S., Sourour, M., Hämäläinen, R., Olsson, C., et al. (2011) · Nature · doi:10.1038/nature09871 · Cited by 954
Laurent, L. C., Ulitsky, I., Slavin, I., Tran, H., Schork, A., Morey, R., Lynch, C., Harness, J. V., Lee, S., Barrero, M. J., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2010.12.003 · Cited by 890 · cited 10×
“4; S2A Table); recurrent duplications of all or part this chromosome in hPSCs have also been described in other studies [3,19].”
BackgroundMethodResultInfluentialSelf-citationIdentification and classification of chromosomal aberrations in human induced pluripotent stem cells
Mayshar, Y., Ben-David, U., Lavon, N., Biancotti, J.-C., Yakir, B., Clark, A. T., Plath, K., Lowry, W. E., & Benvenisty, N. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.07.017 · Cited by 756
Genomic alterations in cultured human embryonic stem cells
Maitra, A., Arking, D. E., Shivapurkar, N., Ikeda, M., Stastny, V., Kassauei, K., Sui, G., Cutler, D. J., Liu, Y., Brimble, S. N., et al. (2005) · Nature Genetics · doi:10.1038/ng1631 · Cited by 619
A bioinformatic assay for pluripotency in human cells
Müller, F.-J., Schuldt, B. M., Williams, R., Mason, D., Altun, G., Papapetrou, E. P., Danner, S., Goldmann, J. E., Herbst, A., Schmidt, N. O., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1580 · Cited by 450
Self-citationPreserving the genetic integrity of human embryonic stem cells
Mitalipova, M. M., Rao, R. R., Hoyer, D. M., Johnson, J. A., Meisner, L. F., Jones, K. L., Dalton, S., & Stice, S. L. (2005) · Nature Biotechnology · doi:10.1038/nbt0105-19 · Cited by 413
Self-citationNazor, K. L., Altun, G., Lynch, C., Tran, H., Harness, J. V., Slavin, I., Garitaonandia, I., Müller, F.-J., Wang, Y.-C., Boscolo, F. S., et al. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.02.013 · Cited by 407
Self-citationMinireview: GNAS: Normal and Abnormal Functions
Weinstein, L. S., Liu, J., Sakamoto, A., Xie, T., & Chen, M. (2004) · Endocrinology · doi:10.1210/en.2004-0865 · Cited by 327
Närvä, E., Autio, R., Rahkonen, N., Kong, L., Harrison, N., Kitsberg, D., Borghese, L., Itskovitz-Eldor, J., Rasool, O., Dvorak, P., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1615 · Cited by 277
Human embryonic stem cells reveal recurrent genomic instability at 20q11.21
Lefort, N., Feyeux, M., Bas, C., Féraud, O., Bennaceur-Griscelli, A., Tachdjian, G., Peschanski, M., & Perrier, A. L. (2008) · Nature Biotechnology · doi:10.1038/nbt.1509 · Cited by 238
Avery, S., Hirst, A. J., Baker, D., Lim, C. Y., Alagaratnam, S., Skotheim, R. I., Lothe, R. A., Pera, M. F., Colman, A., Robson, P., et al. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.10.005 · Cited by 167
Nguyen, H. T., Geens, M., Mertzanidou, A., Jacobs, K., Heirman, C., Breckpot, K., & Spits, C. (2014) · MHR: Basic science of reproductive medicine · doi:10.1093/molehr/gat077 · Cited by 117
Bai, Q., Ramirez, J.-M., Becker, F., Pantesco, V., Lavabre-Bertrand, T., Hovatta, O., Lemaître, J.-M., Pellestor, F., & De Vos, J. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0292 · Cited by 90
FDA scrutinizes human stem cell therapies
Fox, J. L. (2008) · Nature Biotechnology · doi:10.1038/nbt0608-598 · Cited by 22
Nonhuman Primate Models in Translational Regenerative Medicine
Daadi, M. M., Barberi, T., Shi, Q. S., & Lanford, R. E. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0374 · Cited by 22
Ben‐Yosef, D., Boscolo, F. S., Amir, H., Malcov, M., Amit, A., & Laurent, L. C. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.009 · Cited by 11
Self-citation
Cited by
Advanced drug delivery systems and artificial skin grafts for skin wound healing
Kim, H. S., Sun, X., Lee, J.-H., Kim, H.-W., Fu, X., & Leong, K. W. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.014 · Cited by 625
The future of stem cell therapies for Parkinson disease
Parmar, M., Grealish, S., & Henchcliffe, C. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0257-7 · Cited by 306
Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience
Mertens, J., Marchetto, M. C., Bardy, C., & Gage, F. H. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.46 · Cited by 307
Chen, Y., Tristan, C. A., Chen, L., Jovanovic, V. M., Malley, C., Chu, P.-H., Ryu, S., Deng, T., Ormanoglu, P., Tao, D., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01126-2 · Cited by 172
The pluripotent state in mouse and human
Davidson, K. C., Mason, E. A., & Pera, M. F. (2015) · Development · doi:10.1242/dev.116061 · Cited by 179
“Adaptation to single-cell survival is often associated with both epigenetic and characteristic genetic changes (Amps et al., 2011; Garitaonandia et al., 2015), including small amplifications and deletions that might have escaped detection in the studies to date.”
Background
Metadata
- Authors
- Garitaonandia, I., Amir, H., Boscolo, F. S., Wambua, G. K., Schultheisz, H. L., Sabatini, K., Morey, R., Waltz, S., Wang, Y.-C., Tran, H., Leonardo, T. R., Nazor, K., Slavin, I., Lynch, C., Li, Y., Coleman, R., Gallego Romero, I., Altun, G., Reynolds, D., Dalton, S., Parast, M., Loring, J. F., & Laurent, L. C.
- Affiliations
- Scripps Research Institute (US)
- University of California San Diego (US)
- University of Georgia (US)
- Corresponding author
- Loring, Jeanne F.
- Laurent, Louise C.
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-02-25
- Volume
- 10
- Issue
- 2
- Pages
- e0118307
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4340884
- OpenAlex
- W2056795346
- Cited by
- 150
- References
- 25
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 17 · 2023: 16 · 2022: 14 · 2021: 17 · 2020: 13 · 2019: 10 · 2018: 14 · 2017: 15 · 2016: 20 · 2015: 5
- FWCI
- 7.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Knowledge@UChicago (University of Chicago) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- University of Chicago (cc-by)
- Funders
- Autism Speaks
- California Institute for Regenerative Medicine (RT1-01108, CL1‐00502, TG2-01165, TB1-01193, RM1-01717, RN2-00931-1, TR1-01250, 01165)
- Hartwell Foundation
- Wellcome Trust
- National Institutes of Health (GM085354)
- University of California, San Diego
- National Heart, Lung, and Blood Institute (P01HL089471)
- National Institute of Mental Health (R33MH087925)
- National Institute of General Medical Sciences (P01GM085354)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- human embryonic stem cells, induced pluripotent stem cells, genomic instability, epigenetic instability, culture conditions, feeder-free culture, TP53 deletion, teratoma, DNA methylation, global gene expression, cell proliferation, pluripotency
- MeSH terms
- Human Embryonic Stem Cells, Cell Self Renewal, Cell Differentiation, Cell Line, Cell Transformation, Neoplastic, Cells, Cultured, Chromosome Aberrations, Chromosome Deletion, Chromosomes, Human, Pair 12, Chromosomes, Human, Pair 17, Chromosomes, Human, Pair 20, Humans, Phenotype, Time Factors, Genome, Human, Tumor Suppressor Protein p53, Cell Culture Techniques, DNA Methylation, Polymorphism, Single Nucleotide, Gene Expression Profiling, Pluripotent Stem Cells, Genomic Instability, Epigenesis, Genetic, Chromosome Duplication
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.